Application of quercetin to triple negative breast cancer MDA-MB-231 cell KCNH2 current
Through whole-cell patch clamp recording current, the study found that quercetin has an inhibitory effect on triple-negative breast cancer cells, solving the problem of psychological trauma and toxic side effects of breast cancer treatment on young female patients, and providing a new drug theory.
Patent Information
- Application Number
- CN202410997836.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing breast cancer treatment methods cause psychological trauma to young female patients, and the toxic side effects of radiotherapy and chemotherapy are great, and there is a lack of effective drug theory for anti-triple-negative breast cancer cells.
Current recording by whole-cell patch clamp, electrode fluid and electrode fluid were prepared, and current study was performed on triple-negative breast cancer MDA-MB-231 cells, and it was found that quercetin had an inhibitory effect. The specific steps included the preparation of electrode fluid. , electrode contacts cells, record cell membrane capacitance to calculate current density, and verify the inhibitory effect of quercetin through different concentrations and action times.
Quercetin has a significant inhibitory effect on triple-negative breast cancer cells. As the concentration increases and the action time is longer, the inhibitory effect becomes more obvious, providing a new theory of medication to provide a new basis for breast cancer treatment.
Smart Images

Figure CN119023749A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of research on the effect of quercetin on triple-negative breast cancer cell current, and particularly relates to an application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells. Background Art
[0002] Quercetin is widely distributed in many plants. It belongs to the flavonoids and exists mainly in the form of glycosides. It is found in the flowers, leaves, and fruits of plants. The main effects of quercetin are anti-inflammatory and antioxidant, and it also has antibacterial and anti-cancer effects.
[0003] Triple-negative breast cancer is a special subtype of breast cancer. In the hormone receptor detection of breast cancer pathological specimens, the results of estrogen receptor and progesterone receptor are mostly positive, but this type of breast cancer has both hormone receptors negative. Compared with non-triple-negative breast cancer, triple-negative breast cancer occurs at an earlier age, has a larger tumor volume, and has a higher chance of visceral metastasis and bone metastasis. At present, the treatment of breast cancer is mainly surgical. Total mastectomy plus axillary lymph node dissection can achieve radical removal of malignant tumors, which to a certain extent also causes serious psychological trauma to young female patients. Breast cancer is a systemic disease, and after surgery, it needs comprehensive treatment such as adjuvant chemotherapy, radiotherapy, endocrine therapy, biological targeted therapy, and adjuvant therapy of traditional Chinese medicine. Among them, the toxic side effects of radiotherapy and chemotherapy are very large, causing great harm to the patient's body.
[0004] With the discovery of molecular biology and basic medical research, some plant extracts have an inhibitory effect on malignant tumor cells. Therefore, a study proposed the application of quercetin on the KCNH2 current of triple-negative breast cancer MDA-MB-231 cells, providing a new medication theory and basis for the clinical treatment of breast cancer.
[0005] The present application is based on the spirit and concept of seeking excellence, and is assisted by professional knowledge and experience, as well as after many ingenuities and experiments, to create the present invention, and further provides an application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells. Summary of the invention
[0006] The present invention provides an application of quercetin to KCNH2 current of triple-negative breast cancer MDA-MB-231 cells, which solves the problems in the prior art.
[0007] The technical solution of the present invention is achieved as follows: an application of quercetin to KCNH2 current of triple-negative breast cancer MDA-MB-231 cells comprises the following steps: S1. Preparation of electrode solution, the electrode solution includes an electrode external solution and an electrode internal solution, the electrode external solution is composed of 135mmol / L sodium chloride, 5.4mmol / L potassium chloride, 0.33mmol / L sodium dihydrogen phosphate, 10mmol / L HEPAS, 10mmol / L glucose, 1mmol / L magnesium chloride, 2mmol / L tetraaminopyridine, and 0.2mmol / L barium chloride; the electrode internal solution is composed of 140mmol / L potassium chloride, 1mmol / L magnesium chloride, 10mmol / LEGTA, 5mmol / L HEPAS, and 2mmol / L ATP-Na2; S2. Use whole-cell patch clamp to record current, manipulate the electrode into water, find the cell and electrode tip under the microscope, adjust the micromanipulation system to make the electrode tip contact the cell, inhale to apply negative pressure until G seal is formed; S3. Record the cell membrane capacitance to facilitate calculation of current density.
[0008] As a preferred embodiment, the pH of 0.2 mmol / L barium chloride in the electrode external solution is adjusted to 7.40 by sodium hydroxide.
[0009] As a preferred embodiment, the pH of 2mmol / L ATP-Na2 in the electrode solution is adjusted to 7.30 by sodium hydroxide, and the mixed electrode solution is filtered through a 0.22μm microporous filter membrane and then stored in a refrigerator at 4°.
[0010] As a preferred embodiment, the current in the whole-cell patch clamp is recorded using an Axopatch 200B amplifier.
[0011] As a preferred embodiment, the negative pressure applied will break the cell membrane, thereby forming a whole-cell recording mode. As a preferred implementation, the recording mode uses a Step voltage mode and a Ramp voltage mode for recording.
[0012] After adopting the above technical scheme, the beneficial effect of the present invention is as follows: the application of a quercetin proposed by the present invention on the KCNH2 current of triple-negative breast cancer MDA-MB-231 cells found that different concentrations of quercetin have an inhibitory effect on human breast cancer cells, and this inhibitory effect is dependent on the dose and action time of quercetin, that is, with the increase of quercetin concentration and the extension of action time, the inhibitory effect of quercetin on breast cancer cells is more obvious, and the difference between the cell inhibition rate of each concentration group and the control group is significant; under the same concentration, the difference in cell proliferation inhibition rate at different action times is significant; under the same action time, the difference in cell proliferation inhibition rate between each concentration group is significant. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
[0014] Figure 1 This is a schematic diagram of whole-cell patch clamp recording of KV11.1 channel current of the present invention; Figure 2 This is a schematic diagram of quercetin inhibiting KV11.1 current in the present invention. DETAILED DESCRIPTION
[0015] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. Example
[0016] like Figure 1-2 As shown, an application of quercetin to KCNH2 current of triple-negative breast cancer MDA-MB-231 cells comprises the following steps: S1. Preparation of electrode solution, the electrode solution includes an electrode external solution and an electrode internal solution, the electrode external solution is composed of 135mmol / L sodium chloride, 5.4mmol / L potassium chloride, 0.33mmol / L sodium dihydrogen phosphate, 10mmol / L HEPAS, 10mmol / L glucose, 1mmol / L magnesium chloride, 2mmol / L tetraaminopyridine, and 0.2mmol / L barium chloride; the electrode internal solution is composed of 140mmol / L potassium chloride, 1mmol / L magnesium chloride, 10mmol / LEGTA, 5mmol / L HEPAS, and 2mmol / L ATP-Na2; S2. Use whole-cell patch clamp to record current, manipulate the electrode into water, find the cell and electrode tip under the microscope, adjust the micromanipulation system to make the electrode tip contact the cell, inhale to apply negative pressure until G seal is formed; S3. Record the cell membrane capacitance to facilitate calculation of current density.
[0017] Furthermore, the pH of 0.2 mmol / L barium chloride in the electrode external solution is adjusted to 7.40 by sodium hydroxide.
[0018] Furthermore, the pH of 2mmol / L ATP-Na2 in the electrode solution was adjusted to 7.30 by sodium hydroxide, and the mixed electrode solution was filtered through a 0.22μm microporous filter membrane and stored in a refrigerator at 4°.
[0019] Furthermore, the currents in whole-cell patch clamp were recorded using an Axopatch 200B amplifier.
[0020] Furthermore, applying negative pressure will break the cell membrane, forming a whole-cell recording mode. Furthermore, the recording mode adopts the Step voltage mode and the Ramp voltage mode for recording.
[0021] In summary, Figure 1 A is a diagram of the stimulation pulse program, B is a diagram showing the effects of Control (external current solution) and DMSO (0.1% DMSO) on KV11.1 current, and C is a diagram showing the effects of KV11.1-specific inhibitor E-4031 on KV11.1 current; To verify that the recorded ion channel current is KV11.1 current, 20μM E-4031, a channel-specific inhibitor, was added to the control group to observe the current changes before and after. The results showed that 20μM E-4031 significantly and almost completely inhibited the recorded current, indicating that the measured current was KV11.1. In order to exclude the effect of DMSO on the current, the current changes were recorded using an electrode external solution containing 0.1% DMSO. The results showed that there was no difference in the current before and after the application of DMSO, indicating that 0.1% DMSO had no effect on the KV11.1 current.
[0022] In summary, Figure 2 A is the stimulation pulse program diagram, B is the effect diagram of 0.1% DMSO and different concentrations of quercetin on KV11.1 current, C is the concentration effect curve of different concentrations of quercetin on KV11.1 current (n=3), and D is the effect diagram of Control and quercetin on the single root curve of KV11.1 current; To verify the effect of quercetin on the KV11.1 channel current of triple-negative breast cancer MDA-MB-231 cells, different concentrations of quercetin were applied in sequence, and the changes in the original current graph before and after the application of the drug were observed. As the concentration gradient of quercetin increased, the inhibitory effect on the KV11.1 channel current increased successively. In order to intuitively show the effect of concentration changes on the inhibition rate of the KV11.1 channel of cancer cells, the Hill curve was fitted. The inhibition rate increased with the increase of quercetin concentration, and the IC50 was 41.28uM. The inhibitory effects of different concentrations of quercetin on the KV11.1 current were different, and it had a concentration-dependent inhibitory effect.
[0023] The present invention proposes an application of quercetin on the KCNH2 current of triple-negative breast cancer MDA-MB-231 cells, and it is found that different concentrations of quercetin have an inhibitory effect on human breast cancer cells. This inhibitory effect is dependent on the dose and action time of quercetin, that is, as the concentration of quercetin increases and the action time prolongs, the inhibitory effect of quercetin on breast cancer cells becomes more obvious.
[0024] In the description of the present invention, it should be understood that the terms "longitudinal", "lateral", "upper", "lower", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside" and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present invention. In the description of the present invention, unless otherwise specified and limited, it should be noted that the terms "installed", "connected" and "connected" should be understood in a broad sense, for example, it can be a mechanical connection or an electrical connection, or it can be the internal communication of two elements, it can be a direct connection, or it can be an indirect connection through an intermediate medium. For ordinary technicians in this field, the specific meanings of the above terms can be understood according to specific circumstances.
[0025] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. An application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells, characterized in that: The steps include: S1. Preparation of electrode solution, the electrode solution includes an electrode external solution and an electrode internal solution, the electrode external solution is composed of 135mmol / L sodium chloride, 5.4mmol / L potassium chloride, 0.33mmol / L sodium dihydrogen phosphate, 10mmol / L HEPAS, 10mmol / L glucose, 1mmol / L magnesium chloride, 2mmol / L tetraaminopyridine, and 0.2mmol / L barium chloride; the electrode internal solution is composed of 140mmol / L potassium chloride, 1mmol / L magnesium chloride, 10mmol / LEGTA, 5mmol / L HEPAS, and 2mmol / L ATP-Na2; S2. Use whole-cell patch clamp to record current, manipulate the electrode into water, find the cell and electrode tip under the microscope, adjust the micromanipulation system to make the electrode tip contact the cell, inhale to apply negative pressure until G seal is formed; S3. Record the cell membrane capacitance to facilitate calculation of current density.
2. The application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells according to claim 1, characterized in that: The pH of 0.2 mmol / L barium chloride in the electrode external solution was adjusted to 7.40 by sodium hydroxide.
3. The application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells according to claim 1, characterized in that: The pH of 2mmol / L ATP-Na2 in the electrode internal solution was adjusted to 7.30 by sodium hydroxide, and the mixed electrode internal solution was filtered through a 0.22μm microporous filter membrane and then stored in a refrigerator at 4°.
4. The application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells according to claim 1, characterized in that: The currents in the whole-cell patch clamp were recorded using an Axopatch 200B amplifier.
5. The application of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells according to claim 1, characterized in that: The negative pressure applied will break the cell membrane, thus forming a whole-cell recording mode.
6. The use of quercetin on KCNH2 current of triple-negative breast cancer MDA-MB-231 cells according to claim 5, characterized in that: The recording mode adopts the Step voltage mode and the Ramp voltage mode for recording.
